Drawing for SWITCH

USPTO serial 79385437

SWITCH

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
LOZEAU, BRANDON THOMAS
Law office
TMO LAW OFFICE 127

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SWITCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rob LeBlanc

Rob LeBlanc Haynes and Boone, LLP2801 N. Harwood Street, Suite 2300DALLAS, TX 75201United States

Goods and services

ClassDescriptionStatusFirst use
010Medical and surgical equipment for the purpose of delivering humidification and oxygen therapy; anaesthesia respiratory apparatus for medical purposes; capnography apparatus; humidification apparatus for respiratory therapy for medical purposes; anaesthetic and respiratory apparatus and instruments namely respiratory gas mixing apparatus for medical use, respiratory gas blending apparatus for medical use and respiratory gas blowing apparatus for medical use; medical apparatus, namely, invasive and non-invasive ventilation apparatus and instruments; breathing tubes used in the delivery of air and gases to and away from patients; cannulae; nasal cannulae; cannula for respiratory purposes; collapsible cannula for respiratory purposes; breathing tubes and nasal tubes for medical or surgical use; facial masks, oral masks, nasal masks, nasal interfaces, mouthpieces, all being used in the delivery of oxygen, air and other gases for medical and surgical purposes.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 23, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 23, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 2, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 15, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 29, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 31, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 13, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 13, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 28, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 1, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 1, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Mar 1, 2024CNSLSUSPENSION LETTER WRITTEN—
Feb 27, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2024RFNTREFUSAL PROCESSED BY IB—
Jan 24, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 23, 2024RFRRREFUSAL PROCESSED BY MPU—
Jan 5, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 4, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 2, 2024DOCKASSIGNED TO EXAMINER—
Dec 19, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 15, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 14, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance